Wolfgang Stohr
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Pharmacokinetics and safety of fosfomycin and flomoxef administered as part of neonatal sepsis treatment (NeoSep1 Part 1).
Journal: Antimicrobial agents and chemotherapy
Published: December 29, 2025
Neonatal sepsis definitions for randomised-controlled trials: challenges and approaches.
Journal: International journal of epidemiology
Published: October 20, 2025
Longitudinal changes in plasma biomarkers of immune activation, neuronal inflammation and injury in persons with HIV initiating ART.
Journal: HIV medicine
Published: October 02, 2025
Evidence of Poor Utility of Current Sepsis Screening Tools in an At-risk Population of Children With Community-Acquired Pneumonia.
Journal: The Pediatric infectious disease journal
Published: February 19, 2025
Impact of interrupting antiretroviral therapy started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: The SPARTAC trial.
Journal: Journal of virus eradication
Published: March 26, 2024
High-resolution genomics identifies pneumococcal diversity and persistence of vaccine types in children with community-acquired pneumonia in the UK and Ireland.
Journal: BMC microbiology
Published: December 22, 2023
Assessment of three antibiotic combination regimens against Gram-negative bacteria causing neonatal sepsis in low- and middle-income countries.
Journal: Nature communications
Published: November 27, 2023
Determining sample size in a personalized randomized controlled (PRACTical) trial.
Journal: Statistics in medicine
Published: June 22, 2023
Challenges in the Implementation of the NeoOBS Study, a Global Pragmatic Observational Cohort Study, to Investigate the Aetiology and Management of Neonatal Sepsis in the Hospital Setting.
Journal: Antibiotics (Basel, Switzerland)
Published: February 23, 2023
Therapeutic vaccination following early antiretroviral therapy elicits highly functional T cell responses against conserved HIV-1 regions.
Journal: Scientific reports
Published: November 23, 2022
Last Updated: 09/26/2026